Management and treatment of anorexia nervosa: a retrospective cohort study by Teresa Isabel Fernandes Sá
2014/2015
Teresa Isabel Fernandes Sá
Management and Treatment of Anorexia 
Nervosa: a retrospective cohort study
março, 2015
Mestrado Integrado em Medicina
Área: PSIQUIATRIA E SAÚDE MENTAL
Trabalho efetuado sob a Orientação de:
Drª Isabel Brandão
Trabalho organizado de acordo com as normas da revista:
Eating and Weight Disorders - Studies on Anorexia, 
Bulimia and Obesity
Teresa Isabel Fernandes Sá
Management and Treatment of Anorexia 
Nervosa: a retrospective cohort study
março, 2015


  
 
 
 
TÉ Åxâ Ñt|? 
t ÖâxÅ wxäÉ É Åxâ zÉáàÉ ÑxÄt Äx|àâÜt x t ÑÜÉvâÜt |ÇxázÉàöäxÄ ÑxÄÉ átuxÜA 
 
 
 
fi Å|Ç{t Åûx? |ÜÅû x |ÜÅûÉ? 
ÑÉÜ àâwÉA 
 
 
 
fi Å|Ç{t tä™? ctÄÅ|ÜtA 
 
 
1 
 
Original article 
Management and Treatment of Anorexia 
Nervosa: a retrospective cohort study 
Teresa Sá1, Isabel Brandão2, Patrícia Nunes3, Filipa Soares3, Joana Rebelo3, 
António Roma-Torres3 
 
1Faculty of Medicine, University of Porto, Portugal 
2Department of Psychiatry and Mental Health of São João Hospital Center, 
Faculty of Medicine, University of Porto, Portugal 
3Department of Psychiatry and Mental Health of São João Hospital Center, Porto, 
Portugal 
 
Corresponding author: 
Teresa Sá 
Faculdade de Medicina da Universidade do Porto, 
Departamento de Psiquiatria e Saúde Mental, 
Alameda Professor Doutor Hernâni Monteiro,  
4200-319 Porto, Portugal 
 
e-mail: teresa.isabel.sa@gmail.com 
 
Abstract 
Purpose: The main aims of the present study were to present an Anorexia Nervosa (AN) 
treatment program offered in a major university hospital in Portugal, and to determine the 
influence of body mass index (BMI) at admission, on outcome. Our hypothesis is that 
patients with higher severity, based on current BMI, may have worst prognosis with 
poorest outcome. 
Methods: The sample included data from case records of 121 patients seen 
consecutively for the first time at our center, between 2008 and 2012. So we performed a 
retrospective cohort study which included data collected at admission and at 2 follow-up 
years. 
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Results: From the initially selected patients, 54.6% completed treatment and follow-up, 
0.8% died from medical complications and 44.6% dropout. After 2 years of follow-up, 
those admitted at severe/extreme level had an insignificant higher BMI than those in the 
mild/moderate level. Outcomes between groups were similar and no differences in 
relation to the other possible prognostic factors were seen. 
Conclusions: This paper presents a particular model of care for AN patients that in 
general leads to relevant weight gains and decrease psychopathology. According to our 
research, BMI at the start of an outpatient treatment does not seem to be an important 
consideration in outcome or prognostic features. Future research must be done to 
evaluate how different factors may influence the treatment outcome. 
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Introduction 
Eating disorders (EDs) are severe and complex psychiatric pathologies [1,2] 
which are often chronic and most frequently affect young people [2]. They usually cause 
physical, behavioral, emotional and cognitive symptoms [1] with high health risk to 
patients and a challenge to professionals care for [3]. 
The richness and complexity that Anorexia Nervosa (AN) displays as 
psychopathological model such as the increased incidence in recent years justifies the 
interest of the scientific community. Epidemiological data in Portugal are quite scarce, but 
a recent study suggests similar data to other western countries [4] with the mean 
prevalence rate of 0.3% in young female [5], and a 10:1 female to male ratio [6]. AN is 
characterized by persistent restriction of energy intake to maintain a normal body weight 
for age and height, a pathological fear of gaining weight or becoming fat, and disturbance 
in self-perception of weight or body shape [6]. Patients with AN may restrict total food 
intake and extensively exercising matching the restricting subtype (AN-R), or binge/purge 
typically by self-inducing vomiting using laxatives or diuretics, in binge/purging type (AN-
BP) [7]. Adolescence or young adulthood are the most common periods of onset, which is 
often associated with a stressful life event [6]. The course and outcome of AN are highly 
variable and comorbid disorders are common [6].  
There is no strong evidence-based treatment for AN therefore it is expected that 
there will be disagreement about what the most appropriate program [8]. It is a complex 
process partly reflected by the often long and severe course of the disorder, with a large 
group of patients with long-lasting problems, recurrent treatment attempts, dropouts and 
a chronic course [9]. However, there seems to be a common treatment basis which 
typically involves a multidisciplinary approach [10,11]. The São João Hospital Center 
(CHSJ) is a university hospital which is a reference place for EDs treatment, including 
patients from all over the north of Portugal. Our therapeutic program is guided by 
understanding the importance of promoting autonomy and self-initiative of patients. It 
consists of several phases shaping a global design with the ultimate goal of promoting a 
gradual change in eating behavior and subjective experience of patients (Roma Torres, 
1986). In general, evidence on treatment approaches is very limited, so that more 
knowledge about predictors of treatment response and resistance are needed [9]. 
Several studies have argued that premature identification of prognostic features has 
significant implications in therapeutic strategy and treatment outcome, which could lead 
to more targeted and effective interventions [12,13,1]. There are also conflicting reports 
about the role played by body mass index (BMI) at the start of either outpatient or 
inpatient treatment as a predictor of outcome [14].  
The main aims of the present study were to introduce and explore the CHSJ AN 
program and to determine the influence of BMI at admission, on the outcome. Our 
hypothesis is that patients with higher severity level, which can be based on current BMI 
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[9], extreme (BMI<15 Kg/m2) and severe (BMI 15-15.99 Kg/m2), may have worst 
prognosis with poorest outcome, higher dropout rates, inpatient treatment and 
comorbidities, than the moderate (BMI 16-16.99 Kg/m2) or mild (BMI≥17 Kg/m2) level. 
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Material and methods  
Participants 
The sample included 121 patients (114 female, 7 male) seen consecutively for 
the first time at CHSJ in Oporto and evaluated by clinical psychiatric interview, done by 2 
experienced senior psychiatrists. The newest edition of the Diagnostic and Statistical 
Manual of Mental Disorders (DSM-5) includes significant changes within EDs section 
[6,10]. This revised diagnostic criteria resulted in significant changes on EDs prevalence, 
particularly an increase in AN diagnosis, because of the exclusion of the amenorrhea 
criterion [15]. Accordingly, all diagnoses were reviewed and patients who met the latest 
AN criteria, at the time of his first appointment, were admitted. Participants were referred 
to our unit by general practitioners or psychiatrists. Some of them came by themselves or 
following family advice. Eleven patients were directly transferred from the emergency 
room to the psychiatric ward, 7 of them were immediately admitted to inpatient care due 
to severe electrolyte imbalance, physiological instability, very low BMI (<13 Kg/m2) or 
suicide risk. For study inclusion, participants were required to be at least 13 years old and 
met full DSM-5 criteria for AN. Exclusion criteria were pregnancy or lactation patients.  
This study was approved by the ethics committee of CHSJ.  
Data collection 
Data were collected from the case records of patients admitted from January 
2008 until December 2012. Patients were followed at least for 2 years. So we performed 
a retrospective cohort study which included demographic variables (gender, marital 
status, occupation), anthropometric variables (weight and BMI), illness duration, family 
history of EDs or psychiatric disturb, psychiatric comorbidity, inpatient treatment, suicide 
attempts/ideation, psychopharmacological treatment and treatment outcome. 
Although not a decisive marker for healthy weight in adolescents, BMI was used 
as a general measure of health [16]. For the study, we considered weight measured at 
the time of interview and 2 years later. For adolescents, BMI-for-age percentile was 
determined using the Centers for Disease Control and Prevention (CDC) BMI percentile 
calculator. The CDC has applied a BMI-for-age below the 5th percentile suggesting 
underweight for children and teenagers. Nevertheless a BMI above this reference may be 
considered to be significantly underweight, due to the disability to maintain their expected 
growth rate [6]. At our sample, 7 patients are on 5-10th percentile and 2 on the 10-25th, 
with all other adolescents below the 5th percentile. Defining whether weight is less than 
that minimally expected we considered individual body shape, weight and growth history. 
Treatment program 
All patients were treated following the regular practice on Department of 
Psychiatry and Mental Health of CHSJ, which has been developing his own model of care 
(Roma Torres, 1986). The guiding principle of our treatment is the consideration of AN as 
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a self-autonomy conflict with three aspects that should be emphasized: motivation to 
change focused on respect for autonomy and responsibility, eating is not a choice, it is a 
mandatory requirement of nature; nutritional rehabilitation, with minimal diet 
establishment notably concentrated on control health rather than disease; family 
approach involving the relatives but leaving the patient in charge of feeding behavior 
learned throughout the treatment. 
Our program is guided by an interdisciplinary team with psychological, medical, 
nutritional and nursing care. Psychiatric appointments were regularly done. 
Psychotherapy is stablished once refeeding process begins and should last for all stages 
of treatment. It must be centered primarily on eating behavior and weight gain, without 
neglecting emotions. The cognitive behavioral approach aims to change behavior in the 
first place, respecting the individual, its own autonomy, emotion and thought. Attempts to 
promote weight gain might create tension and anxiety therefore we offer a non 
hypercaloric diet (1700 Kcal/day into 6 meals) to obtain a minimum weight compatible 
with health. We do not want to stop patient from being thin but simply accept his own 
option without endangering his health. Our intervention emphasizes nutritional 
reeducation instead of total weight recovery, admitting temporary persistence of low 
weight since there are clear improvements in other health indicators. Finally, the 
importance of family involvement in patient’s recovery is well recognized [17] but 
sometimes family structure can operate in an invasive way, restricting the individual’s 
autonomy and independence [18]. From the beginning of therapy, feeding is something 
that is in charge of patient, obviously according to his current age, without family 
interference and with medical support when difficulties persist. This ensures the principle 
of autonomy, encouraging the patient to take an active role in therapy and reassuring the 
fear of losing control over food, which is a characteristic psychological mechanism of 
anorexic behavior. 
Inpatient care is justified when fatal outcome is to be feared and it is a decision 
that has to be taken according to medical, psychopathological and family reasons. It 
consists in a therapeutic plan with patient and family which may imply the complete 
absence of any visits or contact with relatives, restarted by the therapist´s decision, 
depending on the progress made, according to previous contingent steps scheduled. 
The use of pharmacotherapy has been disappointing therefore it is not 
considered in the treatment strategy however, it may be helpful especially because of 
comorbid disorders. 
Outcome of patients 
There is no agreement on what is considered a positive or negative outcome. In 
this study we considered the following treatment outcome: good outcome (full remission 
or partial remission), poor outcome, death or dropout. Our definition of remission is 
according to the DSM-5 criteria for AN [6]. Full remission was considered as total 
absence of AN symptoms, that had been previously met. Patients were defined in partial 
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remission if they no longer filled the criterion of low body weight but, either intense 
resistance to weight gain and/or disturbances in self-perception criteria, were still met. 
Poor outcome consists on the persistence of all DSM-5 clinical manifestations of AN 
despite the treatment. Defining dropout is another important issue. We considered that 
had left treatment or follow-up on its own initiative, earlier than 2 years, meet the 
requirements. We also distinguished early from later dropout, when patients left during 
the first month or only attended to three sessions or less. 
Statistical analysis 
Descriptive statistics were used to characterize the sample. Continuous variables 
were expressed as mean ± standard deviation (SD) and categorical variables as 
frequency and percentages. Since not all data were normally distributed, both parametric 
(Student´s t-test for independent and paired samples) and non-parametric (Mann-
Whitney) tests were used for continuous data, and Chi square test for categorical data. 
All tests were two tailed and p<0.05 was stablished. All statistical analysis was performed 
using the Statistical Package for Social Sciences (SPSS) for Windows, version 
22.0(Chicago, IL). 
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Results 
Overall sample description   
This study´s population included 121 patients (114 female, 7 male) with a mean 
age of 21.4 ± 7.3 years and a mean BMI of 15.77 ± 1.64 Kg/m2, at admission. Most 
participants are single (88.4%) and living with both parents (82.6%). More than a half 
were students (66.9%), 51 (42.1%) of them were attending high school and 47 (38.8%) 
were graduating or had already completed a college degree. Some patients (12.4%) had 
family history of psychiatric disorders, mainly depressive disorders (6.6%) and 9.1% had 
close relatives (mother, sister, aunt or grandmother) diagnosed with AN. 
At admission, participants had median illness duration of 2.0 years (mean 3.63 ± 
4.94 years, range 0.5–25 years) and the mean age of onset was 17.67 ± 4.72 years. 
Forty seven (38.8%) never tried to find medical advice whereas 28 (23.1%) had attended 
to psychiatric appointment before.  A comorbid psychiatric diagnosis was present in 65 
(53.7%) of them, most commonly a mood disorder/dysthymia (25.6%, n=31), or anxiety 
disorder (9.9%, n=12). Two or more comorbid psychiatric diagnosis were present in 8 
(6.6%). There were 57 patients (54.7%) taking psychopharmacological medications such 
as antidepressants (14.9%, n=18), anxiolytics (4.1%, n=5) or even multiple medications 
concurrently (25.6%, n=31).  
Clinical characteristics considering AN subtypes 
Within the sample, 41.3% of patients had the AN-BP subtype and 58.7% had the 
AN-R subtype. Cross-over between subtypes is common [19], however only 8 subjects 
(6.6%) had their diagnosis changed throughout our study, which may be due to the 
relative short follow-up period. Three AN-R subtype patients developed AN-BP and 5 with 
AN turn into bulimia nervosa (BN). Table 1 presents the patient’s characteristics at 
admission according to AN subtype. AN-R participants are more frequently single and still 
studying. The mean illness duration was significantly higher for AN-BP 4.6 ± 5.4 years, 
than for AN-R 2.9 ± 4.5 years. An evaluation between subtypes did not show any 
difference on gender, educational status or BMI at admission. However, considering 
severity based on BMI groups [6] (mild/moderate ≥16 and severe/extreme<16), in AN-R 
subtype there were significantly more cases of severe/extreme illness and in AN-BP 
predominate mild/moderate disease (p=0.027). Comorbidities are much more frequent in 
AN-BP (p=0.012) with significantly more personality disorders than in the AN-R group 
(12% vs. 2.8%) and at least once in their lifetime, 22% of AN-BP patients had tried or 
thought in suicide versus 1.4% of AN-R patients (p<0.001). At the end of follow-up there 
were no significant differences in BMI, remission or dropout rates among AN subtypes. 
Comorbidities were still more frequent in AN-BP group (69% vs 34.2%, p=0.051), such as 
pharmacotherapy (75.9% AN-BP vs 34.2% AN-R, p=0.01). 
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At the end of follow-up 
From the 121 patients, 66 (54.6%) completed treatment and follow-up, 1 (0.8%) 
died exactly at the end of follow-up from medical complications of the disease, and 54 
were lost at 2-year follow-up, which means a 44.6% dropout rate. The rate of early 
dropout was 9.1% corresponding to 11 patients. Analysis of treatment results revealed 
that 36 patients (29.8%) achieved good outcomes, 15 of them (12.4%) met partial 
remission criteria and 21 (17.4%) reached full remission, while 30 (24.8%) had poor 
outcome. Thirty six individuals (29.8%) had received inpatient treatment, and lifetime 
suicidal ideation/attempt was reported by 9.9% of cases. The mean BMI values for 
patients who remained in the study had significantly risen from 15.73 ± 1.60 Kg/m2 to 
18.16 ± 3.88 Kg/m2 (p<0.001), as well as the weight (41.6 Kg to 48.0 Kg, p<0.001), with 4 
subjects meeting overweight World Health Organization (WHO) criteria (BMI≥25) and 1 
meeting obesity class I (BMI 30.0–34.9). 
Follow-up data between level of severity groups (DSM-5) 
Table 2 summarizes results of follow-up according to illness level of severity. 
After 2 years, those admitted at BMI<16 (severe/extreme level, 14.53 ± 1.08 Kg/m2) had 
an insignificant higher BMI than those in the BMI≥ 16 (mild/moderate level, 17.18 ± 0.64 
Kg/m2), with 18.31 ± 4.84 Kg/m2 vs 18.00 ± 2.36 Kg/m2, p=0.750, respectively. Outcomes 
between groups were similar, with 44.4% of subjects at severe/extreme level achieved 
remission (partial or full) compared to 46.7% of those who met mild/moderate level 
(p=1.000), while 55.6% and 53.3% remained under treatment with poor outcome, for 
each group respectively. Dropout rate reached 39.3% (n=24) in patients admitted at 
BMI<16 and 50% (n=30) of those admitted at BMI≥16, however differences did not fulfill 
statistical significance (p=0.275). Likewise, there was no difference in comorbid 
psychiatric diagnosis (p=0.840), neither nonspecific pharmacotherapy (p=1.000) between 
both groups, at the end of study. Finally, inpatient treatment admissions in 
severe/extreme patients had significantly higher rate (41% vs 18.3%, p=0.009), as well as 
effective number of admissions 0.62 ± 0.86 vs 0.27 ± 0.63, p=0.006, than mild/moderate 
cohort. 
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Discussion 
The primary aim of the current research was to present the AN treatment 
program offered in a major university hospital in Portugal. The goal of CHSJ program is 
not only to achieve a healthy weight but specially to provide skills to promote a full 
sustained recovery. The main innovative feature of our therapeutic strategy is to ensure 
the principle of autonomy while working in three essential aspects: motivation to change, 
nutritional education with non hypercaloric diet and family therapy encouraging the 
patient to take an active role on its own treatment. Accordingly, and in line with previous 
guidelines [17,20], we believe that outpatient programs should be privileged, allowing 
individuals to maintain their routines and social life, applying the newly learned skills in 
their usual environment [21]. 
The problem of very high rate of treatment dropout has been long recognized 
[21]. Data from standard clinical practice reveal that dropout rates have remained so over 
the course of time, regardless of country or treatment modality, reaching 50% or more for 
both outpatient and inpatient samples [11,22]. In our program we had 44.6% dropout rate, 
9.9% of which matching early dropouts, a favorable value compared to previous 
estimates among outpatient eating disorder services of 13–32% [23]. We do not know 
exactly the major reasons for premature treatment termination of our patients but 
resistance to treatment and reluctance to recovery have been long recognized as key-
problems in the treatment, as well as illness duration, treatment type and family variables 
[11].  
The discussion of outcome findings between studies was limited by the lack of 
consistent definitions of outcome criteria [24]. After 2 years, 29.8% of our initial patients 
had good outcomes, 17.4% of them had recovered no longer fulfilling any of diagnostic 
criteria of AN and 12.4% achieved partial remission, having a normal body weight but 
maintaining some psychological symptoms, which is compatible with literature remission 
rates that ranged from 13.2% to 40.5%, depending on the definition used [25]. This wide 
range rates could be explained, not only by the absence of commonly accepted outcome 
criteria, but also by different study methodologies or DSM diagnostic criteria along the 
years [24]. On the other hand, reports on long-term course of AN in adults suggested that 
recovery increased with longer follow-up periods [26] reaching almost half of the surviving 
patients, while about 20% remained chronically ill [13], so that we considered 2 years a 
short term follow-up to achieve conclusive and successful global AN outcome. 
Nevertheless, our treatment proved to be effective in increasing BMI from 15.73 ± 1.60 
Kg/m2 to18.16 ± 3.88 Kg/m2. It also led to relevant weight gains, from initial 41.6 ± 5.8 Kg 
to final 48.0 ± 11.0 Kg which means an increment of about 6.5 Kg. Both high final SD 
were probably due to outliers as result of overweight patients at the end of study.  
There are many factors which have been frequently associated with poor short 
and long-term outcome for AN [12]. One of the most reported prognostic indicators in 
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literature is body weight at the start of treatment [12-14]. Therefore, an additional purpose 
of the present study was to explore the impact of BMI at referral to our unit, on outcome 
and patient prognosis. Contrary to previous findings that have related a lower BMI on 
admission to outpatient treatment with a lower rate [14] or even a higher rate of treatment 
completion [13,14], there were no significant differences in dropout rates among the 
current study groups. The findings of our research do not also suggest a direct 
relationship between initial BMI and outpatient treatment outcome. However, the two 
groups apparently responded differently to treatment, with a much higher increment on 
BMI reached by the severe/extreme group (initial 14.53 ± 1.08 Kg/m2 vs final 18.31 ± 4.84 
Kg/m2, p<0.001) comparing to the mild/moderate group (initial 17.18 ± 0.64 Kg/m2 vs final 
18.00 ± 2.36 Kg/m2, p=0.056). So low body weight at the start of treatment is one factor 
that has been suggested to strongly influence treatment outcome [14,27] but according to 
our study it does not seem to clearly affect outpatient approaches. As in another studies, 
our patients presented different psychiatric comorbidities remaining unclear if these are 
secondary to the AN or if they simply shared etiological framework [21]. Again, by the end 
of follow-up, no differences with respect to comorbidity or suicide attempts/ideation rates 
along the study were noted between severity groups, which seem to be more related to 
the type of AN present. On the other hand and as expected, there was a significantly 
higher rate of hospitalizations in the severe/extreme group, with almost a half of the 
patients to be hospitalized at least once.  
According to our research, BMI at the start of an outpatient treatment does not 
seem to be an important consideration in outcome or prognostic features. These findings 
oppose other studies that had considered that BMI at admission to inpatient units seems 
to select severe patients who are less compliant with treatment, which leads to dropout 
and contributes to poor prognosis [27,28]. 
The present study has several limitations that should be considered. It was a 
retrospective medical chart review whereby the information collected was dependent 
exclusively on case records. Since standardized measures were not used, our data are 
mainly clinical which limits the generalizability of our findings. On the other hand, the 
recruitment of subjects from a single center with a large catchment area, treated by the 
same experienced therapists, can be considered a strength of this study. For future 
research, it could be useful to examine data on the long-term outcome of patients and 
readmission rates over the course of a longer follow-up period.  
In conclusion, this paper presents a particular model of care for AN patients 
based on outpatient treatment that in general leads to relevant weight gains and 
decrease psychopathology during the therapeutic approach and up to 2 years of follow-
up. The lack of consensual definition of remission creates difficulties when comparing 
outcome data from treatment modalities and centers, so we emphasize the need for 
uniform adoption of remission definitions [25]. Furthermore, the high incidence of dropout 
as in the case of the majority of literature [29,11], largely decreases the power and 
generalization of the results.  
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Clearly, many factors are related to the recovery process of whatever treatment 
and BMI should only be a guide. In order to fully understand it, future research must be 
done to evaluate how differences in areas like motivation to change, therapeutic alliance 
or treatment acceptance, considered the biggest challenges in the management of 
patients with AN [30], may influence the treatment outcome. 
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Table 1 Sample characteristics at admission according to type of anorexia nervosa 
 
    
  AN-R AN-BP p-value  
n = 71 n = 50 
Demographic % 
      
Gender 
Female 91.5 98.0 0.237 
Male 8.5 2.0 
Marital status 
 
Single 94.4 80.0 
0.042* Married 4.2 18.0 
Common law marriage 1.4 2.0 
Educational status 
 
University 36.6 43.8 
0.336 
High school 46.5 37.5 
Junior high school (9th grade) 15.5 14.6 
Preparatory education (6th grade) 1.4 0.0 
Primary education (4th grade) 0.0 4.2 
Occupation 
 
Employee 15.5 24.0 
0.007* Unemployed 7.0 24.0 
Student 77.5 52.0 
 
Clinical History 
    
  
Age at onset 16.9 ± 4.3 18.8 ± 5.1 0.044* 
Age at first appointment 19.8 ± 5.9 23.6 ± 8.4 0.001* 
Illness duration 2.9 ± 4.5 4.6 ± 5.4 0.021* 
BMI at admission 15.50 ± 1.7 16.08 ± 1.5 0.051 
Severity based on BMI (DSM-5)% 
 
Mild/Moderate 40.8 60.0 0.027* 
Severe/Extreme 59.2 38.0 
Comorbidities at admission % 
 
No 59.2 28.0 0.010* 
Yes 40.8 72.0 
Substance abuse 0.0 2.0 
 
Mood disorder or dysthymia 19.7 34.0 
Anxiety disorder 7.0 14.0 
Obsessive compulsive disorder 5.6 2.0 
Personality disorder 2.8 12.0 
2 or more 5.6 8.0 
Pharmacotherapy at admission % 
 
No 66.2 34.0 0.010* 
Yes 33.8 66.0 
Anxiolytics  2.8 6.0 
 
Antidepressants 12.7 18.0 
Hypnotics 1.4 0.0 
Antipsychotics 1.4 2.0 
2 or more 15.5 40.0 
Inpatient admissions % 
 
Yes 25.4 36.0 0.230 
No 74.6 64.0 
            
* Significant at p< 0.05 
Data are present as mean ± standard deviations or percentages and are based on 
available data only (i.e. missing or unknown data were excluded) 
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Table 2 Follow-up data according to illness level of severity 
 
    
  
Mild/moderate 
(BMI≥16) 
Severe/extreme 
(BMI<16) p-value 
    
  Clinical History at 2 years of follow-up n= 30 n= 37   
BMI 18.00 ± 2.36 18.31 ± 4.84 0.736 
Comorbidities % 
 
No 53.3 48.6 0.840 
Yes 46.7 51.4 
Mood disorder/dysthymia 16.7 21.6 
 
Anxiety disorder 6.7 8.1 
Personality disorder 10.0 2.7 
2 or more 13.3 18.9 
Pharmacotherapy  % 
 
No 46.7 48.6 1.000 
Yes 53.3 51.4 
Antidepressants 16.7 10.8 
 
2 or more 36.7 40.5 
 
Remission 
 
Good outcome (Partial/Full) 46.7 44.4 1.000 
Poor outcome 53.3 55.6 
 
 
Other possible prognostic factors  n= 60 n= 61   
Inpatient admissions % 
 
No 81.7 59.0 0.009* 
Yes 18.3 41.0 
Number of inpatient admissions  0.27 ± 0.63 0.62 ± 0.86 0.006* 
Suicide attempts/ideation % 
 
 
No 86.7 93.4 0.240 
Yes 13.3 6.6 
 
Outcomes % n= 60 n= 61   
 
Full remission 16.7 19.7 
 
 
Partial remission 6.7 6.6 
 
Poor outcome 26.7 32.8 
 
Death 0.0 1.6 
 
Dropout 38.3 32.8 
 
Early dropout 11.7 6.6 
Dropout 
 
Yes 50.0 39.3 0.275 
No 50.0 60.7 
            
* Significant at p< 0.05 
Data are present as mean ± standard deviations or percentages and are based on 
available data only (i.e. missing or unknown data were excluded) 
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